Adona


Combined with:

Transamin

Indications and Reactions:

Role Indications Reactions
Secondary
Compression Fracture 15.1%
Behcet's Syndrome 12.0%
Herpes Zoster 11.2%
Cough 7.6%
Non-small Cell Lung Cancer 7.2%
Drug Use For Unknown Indication 6.8%
Constipation 4.0%
Haemorrhoids 4.0%
Prophylaxis 4.0%
Tumour Associated Fever 4.0%
Antiemetic Supportive Care 3.2%
Cerebral Infarction 3.2%
Gastritis Prophylaxis 3.2%
Haemoptysis 3.2%
Spinal Osteoarthritis 3.2%
Transfusion 2.0%
Haematemesis 1.6%
Infection 1.6%
Lung Cancer Metastatic 1.6%
Pneumonia 1.6%
Cerebral Infarction 14.3%
Haemoptysis 14.3%
Glaucoma 8.6%
Toxic Epidermal Necrolysis 8.6%
Urticaria 8.6%
Cerebral Haemorrhage 5.7%
Decreased Appetite 5.7%
Prostate Examination Abnormal 5.7%
Agranulocytosis 2.9%
Cholestasis 2.9%
Deafness 2.9%
Death 2.9%
Drug Eruption 2.9%
Eosinophil Count Increased 2.9%
Hepatic Function Abnormal 2.9%
Pyrexia 2.9%
Thrombocytopenia 2.9%
Thrombosis 2.9%
Concomitant
Prophylaxis 20.7%
Drug Use For Unknown Indication 20.2%
Product Used For Unknown Indication 13.9%
Hypertension 8.6%
Constipation 4.8%
Cancer Pain 3.5%
Aplastic Anaemia 3.0%
Myelodysplastic Syndrome 2.8%
Insomnia 2.5%
Renal Cell Carcinoma 2.3%
Gastric Ulcer 2.2%
Haemoptysis 2.1%
Iron Overload 2.0%
Diabetes Mellitus 2.0%
Pneumonia 1.8%
Gastrointestinal Haemorrhage 1.8%
Idiopathic Thrombocytopenic Purpura 1.7%
Metastatic Renal Cell Carcinoma 1.5%
Macular Degeneration 1.4%
Chronic Myeloid Leukaemia 1.4%
White Blood Cell Count Decreased 14.4%
Pneumonia 9.2%
Platelet Count Decreased 8.6%
Sepsis 6.6%
White Blood Cell Count Increased 5.8%
Pyrexia 5.2%
Vitreous Haemorrhage 5.2%
Vomiting 4.9%
Interstitial Lung Disease 4.6%
Renal Impairment 4.3%
Thrombocytopenia 4.3%
Hepatic Function Abnormal 3.7%
Hypoglycaemia 3.5%
Gastrointestinal Haemorrhage 3.2%
Neutrophil Count Decreased 3.2%
Rash 2.9%
Liver Disorder 2.6%
Pancytopenia 2.6%
Purpura 2.6%
Respiratory Failure 2.6%

Drug Data